FitLife Brands, Inc. (FTLF) stock

FTLFNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 4/3019% above fair value

$8.48+0.18 (+2.17%)

Close on Nov 13, 2026Market cap $79.64MP/E 44.6Yield –

FitLife Brands r&d expenses

Research and development expenses are spending on new products and technology.

FitLife Brands has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Parsed from the XBRL in FitLife Brands's annual and quarterly filings with the SEC
Per-share figures adjusted for the 2-for-1 split on Feb 7, 2025
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is FTLF.

Gross margin12.3% · median 65.4%

Operating margin3.8% · median 0.9%

Net margin1.9% · median -1.1%

Advertisement
300 × 250

See a number that looks wrong?